Literature DB >> 34021774

Validity and Reliability of the Turkish Translation of the Yale Pharyngeal Residue Severity Rating Scale.

Yavuz Atar1, Sevgi Atar2, Can Ilgin3, Melis Ece Arkan Anarat4, Ugur Uygan4, Yavuz Uyar4.   

Abstract

This study aimed to assess the validity and reliability of the Turkish translation of the Yale pharyngeal residue severity rating scale. The scale measures the severity of residue in the vallecula and pyriform sinus. The original scale was translated into Turkish by two bilingual English-Turkish translators, and the Turkish version was translated back into English by two qualified professional translators to assess accuracy. The evaluators were divided into two groups (training and no-training) and two subgroups according to their experience. Intra-rater, inter-rater, and intra-class correlation coefficient measurements were analyzed by calculating agreement rates, kappa, and p values. In the analysis of the reliability, intra-class correlation coefficient values in the overall ratings for both the vallecula and the pyriform sinus were 0.9996 (95% CI 0.9992-0.9998) and 0.9997 (95% CI 0.9995-0.9999), respectively (p < 0.01). High agreement (> 95%) and perfect Fleiss kappa values were obtained for the vallecula and pyriform sinus ratings in the inter-rater initial assessments (κ = 0.959 and κ = 0.967, respectively). Perfect kappa values were found in the intra-rater results for both the vallecula and pyriform sinus (α = 0.9959 and κ = 0.9959, respectively). In the inter-rater secondary analysis, the vallecula and pyriform sinus kappa values were perfect (κ = 0.959 and κ = 0.967, respectively). In the intra-rater analysis, perfect kappa values were obtained for the vallecula and pyriform sinus in the no-training group and less-experience subgroup (κ = 0.9918 and κ = 1.0 for the vallecula, and κ = 1.0 and κ = 0.9902 for the pyriform sinus, respectively) In the inter-rater analysis, perfect kappa values were obtained for the vallecula and pyriform sinus in the no-training group and less-experience subgroup (κ = 0.9507 and κ = 0.9606 for the vallecula, and κ = 0.9836 and κ = 1.0 for the pyriform sinus, respectively). The Turkish translation of the Yale pharyngeal residue severity rating scale demonstrated high validity and reliability scores in determining pharyngeal residue location and value in the fiberoptic endoscopic evaluation of swallowing.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Pharyngeal residue; Pyriform sinus; Scale; Swallowing; Therapy; Validity; Vallecula

Mesh:

Year:  2021        PMID: 34021774     DOI: 10.1007/s00455-021-10316-1

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  3 in total

1.  Pooling score: an endoscopic model for evaluating severity of dysphagia.

Authors:  D Farneti
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-06       Impact factor: 2.124

2.  Detection of Aspiration, Penetration, and Pharyngeal Residue During Flexible Endoscopic Evaluation of Swallowing (FEES): Comparing the Effects of Color, Coating, and Opacity.

Authors:  James A Curtis; Zeina N Seikaly; Avery E Dakin; Michelle S Troche
Journal:  Dysphagia       Date:  2020-05-11       Impact factor: 3.438

3.  Adding Endoscopist-Directed Flexible Endoscopic Evaluation of Swallowing to the Videofluoroscopic Swallowing Study Increased the Detection Rates of Penetration, Aspiration, and Pharyngeal Residue.

Authors:  Won Young Park; Tae Hee Lee; Nam Seok Ham; Ji Woong Park; Yang Gyun Lee; Sang Jin Cho; Joon Seong Lee; Su Jin Hong; Seong Ran Jeon; Hyun Gun Kim; Joo Young Cho; Jin Oh Kim; Jun Hyung Cho; Ji Sung Lee
Journal:  Gut Liver       Date:  2015-09-23       Impact factor: 4.519

  3 in total
  1 in total

1.  Reliability and Construct Validity of the Yale Pharyngeal Residue Severity Rating Scale: Performance on Videos and Effect of Bolus Consistency.

Authors:  Sara Rocca; Nicole Pizzorni; Nadia Valenza; Luca Negri; Antonio Schindler
Journal:  Diagnostics (Basel)       Date:  2022-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.